Objective: In this study, we aimed to determine the clinical features of patients with recurrent pericardial effusion. We also aimed to evaluate the clinical course and the outcomes of the patients with recurrent pericardial effusion who underwent percutaneous and surgical interventions.
INTRODUCTION
Pericardial effusion is a common finding in clinical practice occurring either as an incidentally or a manifestation of a systemic or cardiac disease. Unfortunately, there are few data regarding the clinical and prognostic features of recurrent effusions in the clinical setting.
It is unclear whether percutaneous or surgical treatment strategies should be changed based on etiology in patients with massive pericardial effusion. However currently appropriate treatment and diagnosis should include complete and permanent drainage, and adequate histological, cytological and microbiological material. In addition, the applied method should have minimal mortality and morbidity rates 1 .
According to 2015 European Society of Cardiology (ESC) pericardial diseases guideline; urgent pericardiocentesis is recommended if the etiology score, clinical presentation score and the imaging method score is over 6, while follow-up is recommended if the score is below 6 2 .
The first known pericardial drainage operation was performed by Larrey 3 .Since then, many techniques have been developed. However, subxiphoid pericardial drainage currently the most popular technique for massive pericardial effusion. Nowadays, with the development of imaging modalities, percutaneous drainage is performed excessively with echocardiography. However, surgery is unavoidable in some cases such as frequent recurrences and adhesions. In fact, occasional pericardial pleural window operations are mandatory.
In this study we evaluated the clinical features and mortality rate of the patients who undergone percutaneous or surgical pericardial drainage due to recurrent massive pericardial effusion.
MATERIAL AND METHODS
In this study, we retrospectively evaluated 22 patients with recurrent massive pericardial effusion causing tamponad, admitted to Afyonkarahisar state hospital between 2001-2016. Patients were treated with interventional methods including percutaneous or surgical drainage. Besides, patients were investigated in terms of age, sex, etiology, laboratory values, quality and quantity of drainage fluid, drainage method, time of the recurrences-duration , and mortality parameters.
All surgical subxiphoid pericardiostomies were performed under local anesthesia and sedation. None of the cases required general anesthesia. After the incision was made about 3 cm below and above the xiphoid process, xiphoid was cut with a scissors. When the pericardium was visualized, 2 cm incision was performed with the appropriate surgical instruments. In addition, pericardial biopsies with cytologic and microbiological samples were taken from pericardial fluid. A 32 fr tube was placed into the mediastinum after the procedure. The tube wasn't removed until the pericardial drainage stop. The drain was removed approximately at fourth day after the procedure. Sclerosing agents such as pericardial powder or tetracycline were not administrated. There was no mortality during surgery.
Percutaneous drainage was chosen for patients with unstable hemodynamic status and for those who were unsuitable for open surgery. Also, percutaneous drainage was performed under the local anesthesia with sterile conditions. All interventions were performed with transthoracic echocardiography. At first a 18 gauge introducer needle was inserted to pericardium then agitated saline injected to the pericardium to confirm to localization of needle. Then a 12 fr Double lumen dialysis catheter was placed in mediastinum with a guide wire. Haemovac drains were connected to the ends of both catheters. Cytological and microbiological samples were taken from drainage fluid. However, pericardial biopsy wasn't performed to these patients.
Statistical Analysis:
Statistical analyses were performed with SPSS 24 package statistical program (StataCorp LP, College Station, TX, USA continuous variables were expressed as mean ± standard deviation (SD) and categorical variables were expressed as frequency and percentage (%).
RESULTS
We evaluated 22 patients with recurrent pericardial effusion. The mean age of the patients was 60 ± 16 and 64% were male ( Table 1 ). The etiology of the pericardial effusion consists of 31% malignancy, 27% idiopathic, 13,5% chronic renal failure, 13,5% postcardiotomy syndrome, 10% autoimmune disease, and 5% congestive heart failure. 9(40.9%) patients died in one year follow up. Of the dead patients 55,5% had malignity, 22,2% had postcardiotomy syndrome and 22,2% had renal failure ( Table 2 ).On the laboratory parameters, creatinine was minimally high (1.29 mg / dL) and calcium (8,06 mg / dL), albumin (3,29 mg / dL) and total protein (6,20 mg / dL) were minimally low. Lactate dehydrogenase (LDH) (504,76 U / L) was very high. There were no distinctive differences in other laboratory values ( Table 3 ). Of the first interventions, 73% were percutaneous drainage, while the remaining 27% were surgical drainage. In the second interventions, the rate of surgical and percutaneous methods was 86.5% and 13.5% respectively. In first intervention, mean drained fluid volume was 668.75 ml in subxiphoid and 483.3 ml in percutaneous drainage. In the second intervention, mean drained fluid volume of subxiphoid and percutaneous drainage was 621.05 ml and 505.6 ml respectively ( Table  4 ).The characteristics of pericardial fluid in first drainages include 59.5% serohemorrhagic, 27% serous and 13.5% hemorrhagic and those in second intervention include 68.1% serohemorrhagic, 22.7% serous and 9.2% hemorrhagic ( Table 5 ). Median duration of recurrence was 46 days (interquartile range 16-78 days). 4 . In our study, 1-year mortality of recurrent malignancy was 71.5%.
Without these known factors, there are rarely observed factors that cause recurrent effusion. One of these factors is surgically treated case of pellet injury that caused recurrent effusion in a 12 year old girl 5 .
In a study of Altıntaş et al, Subxiphoid drainage and drainage with lateral thoracotomy technique were compared and there was no significant differences regarding mortality and mobility between both techniques. In our study, surgical drainage was performed by subxiphoid to all patients.
In a study of Yüksel et al., uremic pericarditis was the most common etiology, followed by malignancy and idiopathic effusions. Subxiphoid drainage was observed to be safe and effective in the treatment of patients with pericardial effusion 7 . However, this study included only patients who had undergone first drainage. The higher rate of malignancy in our study can be explained by the higher recurrence rate.
Various techniques had been tried for the treatment of pericardial effusion other than surgical treatment and percutaneous drainage. Pericardial talc, tetracycline and cisplatin are some of these treatment choices. Pericardial cisplatin is applied especially in malignancy related effusions 8 . In the treatment of effusion related with malignancy, thiotepa, bleomycin, mitoycin, mitoxantrone, radioactive chromic phosphate and OK-432 were also applied instead of cisplatin in the treatment of malignancy related effusions.
CONCLUSION
Mortality rate is higher in patients with recurrent effusion related to malignancy, regardless of treatment strategies or features. Recurrent effusions related to idiopathic, autoimmune diseases and congestive heart diseases are more benign etiologies in terms of mortality.
